Connor, Clark & Lunn Investment Management (CC&L)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-42,289
| Closed | -$13.4M | – | 1751 |
|
|
2023
Q4 | $13.4M | Sell |
42,289
-10,401
| -20% | -$3.29M | 0.06% | 238 |
|
|
2023
Q3 | $8.91M | Buy |
52,690
+10,779
| +26% | +$1.82M | 0.05% | 272 |
|
|
2023
Q2 | $9.09M | Buy |
41,911
+2,171
| +5% | +$471K | 0.05% | 270 |
|
|
2023
Q1 | $7.22M | Buy |
39,740
+4,094
| +11% | +$744K | 0.04% | 303 |
|
|
2022
Q4 | $7M | Sell |
35,646
-3,947
| -10% | -$776K | 0.04% | 287 |
|
|
2022
Q3 | $8.91M | Buy |
+39,593
| New | +$8.91M | 0.06% | 220 |
|